JP2016509067A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509067A5
JP2016509067A5 JP2015559259A JP2015559259A JP2016509067A5 JP 2016509067 A5 JP2016509067 A5 JP 2016509067A5 JP 2015559259 A JP2015559259 A JP 2015559259A JP 2015559259 A JP2015559259 A JP 2015559259A JP 2016509067 A5 JP2016509067 A5 JP 2016509067A5
Authority
JP
Japan
Prior art keywords
npc
pharmaceutical composition
therapeutic agent
composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015559259A
Other languages
English (en)
Japanese (ja)
Other versions
JP6309980B2 (ja
JP2016509067A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/018211 external-priority patent/WO2014130994A1/en
Publication of JP2016509067A publication Critical patent/JP2016509067A/ja
Publication of JP2016509067A5 publication Critical patent/JP2016509067A5/ja
Application granted granted Critical
Publication of JP6309980B2 publication Critical patent/JP6309980B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015559259A 2013-02-25 2014-02-25 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法 Expired - Fee Related JP6309980B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361768929P 2013-02-25 2013-02-25
US61/768,929 2013-02-25
PCT/US2014/018211 WO2014130994A1 (en) 2013-02-25 2014-02-25 Nanoparticles for controlled release of anti-biofilm agents

Publications (3)

Publication Number Publication Date
JP2016509067A JP2016509067A (ja) 2016-03-24
JP2016509067A5 true JP2016509067A5 (https=) 2017-03-30
JP6309980B2 JP6309980B2 (ja) 2018-04-11

Family

ID=51391907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015559259A Expired - Fee Related JP6309980B2 (ja) 2013-02-25 2014-02-25 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法

Country Status (7)

Country Link
US (1) US9566247B2 (https=)
EP (1) EP2958557B1 (https=)
JP (1) JP6309980B2 (https=)
CN (1) CN105142620B (https=)
AU (1) AU2014218569B2 (https=)
CA (1) CA2902157A1 (https=)
WO (1) WO2014130994A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
CN107406556B (zh) * 2015-03-04 2020-07-17 陶氏环球技术有限责任公司 作为用于不良水溶性物质从固体混合物有效增溶的赋形剂的共聚物
WO2017070578A1 (en) 2015-10-21 2017-04-27 The Regents Of The University Of Michigan Detection and treatment of caries and microcavities with nanoparticles
WO2017176796A1 (en) 2016-04-04 2017-10-12 University Of Virginia Patent Foundation Compositions and methods for preventing and treating disease
US20210330599A1 (en) * 2016-08-01 2021-10-28 University Of Rochester Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
CN106370636B (zh) * 2016-08-31 2019-02-26 中国科学院新疆生态与地理研究所 一种检测生物膜表面吸附纳米颗粒的方法
EP3585351A4 (en) * 2017-02-23 2020-12-30 Alira Health Boston LLC ECOPHILIC ANTIMICROBIAL FORMULATIONS DISRUPTING BIOFILMS, THEIR DEVELOPMENT AND THEIR USES
BR112019018084A2 (pt) * 2017-03-03 2020-03-24 The Procter & Gamble Company Métodos para quantificar íons em um biofilme dental
EP3612570A4 (en) * 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
US11291613B2 (en) 2017-05-16 2022-04-05 Johnson & Johnson Consumer Inc. Coated particles and their uses
DE102017130893A1 (de) * 2017-12-21 2019-06-27 Paul Hartmann Ag pH regulierende Wundauflage
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3847442A4 (en) 2018-09-06 2022-10-12 GreenMark Biomedical Inc. SYSTEM FOR TOOTH IMAGING AND/OR HARDENING
CN109091453A (zh) * 2018-09-18 2018-12-28 成都爱睿康美医疗科技有限责任公司 葡萄糖响应性的可注射纳米凝胶及其制备方法和应用
CN113226379A (zh) * 2018-10-22 2021-08-06 武田药品工业株式会社 靶向内体中g蛋白偶联受体的纳米颗粒封装
CN109827814A (zh) * 2019-03-11 2019-05-31 南京大学 一种新型大气颗粒物琼脂采样膜制备及免溶剂提取细胞暴露方法
WO2020198468A1 (en) * 2019-03-26 2020-10-01 Temple University-Of The Commonwealth System Of Higher Education Smart composite with antibiofilm, mineralizing, and antiinfection therapeutic effects
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
DE102019122569A1 (de) 2019-08-22 2021-02-25 Mühlbauer Technology Gmbh Flavonoidderivat
US12509559B2 (en) 2019-10-28 2025-12-30 Brown University Bacterial beta-lactamase responsive hydrogels
US20210179884A1 (en) 2019-12-17 2021-06-17 Columbia Insurance Company Redox chased suspension bead additives for paints and stains
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
WO2023091676A1 (en) * 2021-11-19 2023-05-25 The Regents Of The University Of Michigan Biofilm-targeting nanoparticles to increase the anticaries effect of fluoride
EP4543993A1 (en) 2022-07-11 2025-04-30 Benjamin Moore & Co. Nonionic resins, and mixtures of nonionic resins with cationic additives for stain blocking architectural compositions
CN115671264B (zh) * 2023-01-04 2023-03-07 云南伦扬科技有限公司 一种用于靶向光催化变形链球菌生物膜的级联纳米酶
WO2024226999A1 (en) * 2023-04-28 2024-10-31 Brown University Methods of making and using nanoparticles for treatment of microbial biofilms
CN116570734B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有靶向功能的核壳壳结构药物胶束及其制备方法
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems
CN118955827B (zh) * 2024-07-31 2025-09-12 安徽农业大学 一种纳米载体及其制备方法和应用
CN120324589B (zh) * 2025-04-17 2026-03-27 陕西佰济生物研发有限公司 一种响应式释放微胶囊及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116602A (en) * 1989-09-27 1992-05-26 Colgate-Palmolive Company Antiplaque oral compositions
BRPI0314042B8 (pt) * 2002-09-06 2021-05-25 Calando Pharmaceuticals Inc polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
WO2005030174A1 (en) 2003-09-23 2005-04-07 Massachusetts Institute Of Technology Ph-triggered microparticles
CA2605551A1 (en) * 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering rnaiii-inhibiting peptides
US8119162B2 (en) * 2005-11-10 2012-02-21 Colgate-Palmolive Company Particles that disrupt or impede bacterial adhesion, related compositions and methods
NZ569756A (en) 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
US20100021391A1 (en) * 2006-07-14 2010-01-28 Montana State University Novel nanoparticles for biofilm targeting
US8188068B2 (en) 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
KR101764427B1 (ko) 2008-05-13 2017-08-02 유니버시티 오브 워싱톤 미셀성 어셈블리
EP2313101A4 (en) * 2008-07-09 2014-05-21 Univ Nebraska FUNCTIONAL MICELLES FOR HARD FIBER-RELATED CHEMICAL RELEASE RELEASE
EP2335073A4 (en) * 2008-09-02 2012-09-26 Univ Maryland DIAGNOSIS OF BIOFILM IN VIVO INFECTION AND TREATMENT
US9089677B2 (en) 2011-01-25 2015-07-28 The Regents Of The University Of California Transcutaneous multimodal delivery system (TMDS)

Similar Documents

Publication Publication Date Title
JP2016509067A5 (https=)
US8153617B2 (en) Bridged polycyclic compound based compositions for coating oral surfaces in humans
CN111148499B (zh) 抗微生物颗粒及其使用方法
US10695301B2 (en) Veterinary cannabinoid and menthol compositions and methods
TR200200562T2 (tr) Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
AU2008218275B2 (en) Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US20090196908A1 (en) Edible film-strips with modified release active ingredients
US9452037B2 (en) Delivery of oral care products
Costa et al. Should local drug delivery systems be used in dentistry?
JP2009298801A5 (https=)
JP2016513736A5 (https=)
BRPI0315142B8 (pt) cápsula de lanzoprazol de liberação modificada
US8188068B2 (en) Bridged polycyclic compound based compositions for coating oral surfaces in pets
CN108472251B (zh) 口腔用制剂
Afkhami et al. Application of nanomaterials in endodontics
JP2019515873A5 (https=)
WO2001013898A3 (en) Pharmaceutical formulations with different release times
Mombelli et al. Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state
Arunachalam et al. Perioceutics in the management of Periodontal Disease
CL2007003451A1 (es) Composicion farmaceutica solida oral que comprende un principio activo y polivinilpirrolidona (pvp) entre 1,0-25%, cpaa entre 0,5-10%, el principio activo consiste en una sal hidrosoluble de metal alcalino, de metal alcalino-terreo, una sal de mezcla
JP2017518273A5 (https=)
US11278566B2 (en) Agent for use for inflammatory conditions of mucous membranes
JP2017511350A5 (https=)
Pattnaik et al. Periodontal muco-adhesive formulations for the treatment of infectious periodontal diseases
CN114144167A (zh) 用于口腔的控释装置